Below is Validea's guru fundamental report for MEDTRONIC PLC (MDT). Of the 22 guru strategies we follow, MDT rates highest using our Multi-Factor Investor model based on the published strategy of Pim ...
Medtronic boasts strong free cash flow, stable dividends, and innovation focus, but faces macro headwinds, high debt, and competitive pressures. Recent strategic portfolio moves, including spin-offs ...
Initiate Medtronic with Strong Buy, $161 PT, citing a structural margin inflection from Diabetes spin-off and robust innovation pipeline (120+ approvals). Street underestimates FY27 margin/EPS upside ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback